Lumida
/PGEN
⌘K
Precigen Inc

Precigen Inc

PGEN
$6.85USD+2.54%+0.17 today

MARKET CAP

2.5B

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$3
$8

AI Summary

Stalk
StalkMedium

PGEN remains in a Stage 2 advancing structure above the 50-day SMA, but the active Bullish Exhaustion pattern at late-August highs signals waning upside momentum. Price is pulling back into declining 9- and 20-day EMAs with RSI in a neutral range, offering a buy-on-dip setup. Medium-term bias stays bullish, while short-term timing is neutral—entries are best deferred until clear acceptance off the EMA zone.

  • Q2 revenue $55M; Papimius sales $53.1M, up 145% QoQ
  • FDA approval and 7-year orphan drug exclusivity for RRP therapy
  • Insiders sold ~235K shares (~$1.38M), flagging possible concern
Full analysis →
Insider Trades29 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 6, 2026SellPGENRutul R ShahChief Operating Officer32,739$6.86$2.5B-11.21%+129.10%$224.6K-6.58%10b5-1Stalk
Aug 3, 2026SellPGENRutul R ShahChief Operating Officer67,544$4.42$2.5B-11.21%+129.10%$298.2K+0.00%10b5-1Stalk
Jul 31, 2026SellPGENHarry Jr. ThomasianChief Financial Officer100,000$6.06$2.5B-11.21%+129.10%$606.0K-28.21%10b5-1Stalk
Jun 29, 2026SellPGENRutul R ShahChief Operating Officer85,848$4.09$2.5B-11.21%+129.10%$351.1K+0.00%10b5-1Stalk
Jun 29, 2026SellPGENHarry Jr. ThomasianChief Financial Officer200,000$5.57$2.5B-11.21%+129.10%$1.1M-18.51%10b5-1Stalk
Jun 29, 2026SellPGENHelen SabzevariPresident and CEO693,672$4.11$2.5B-11.21%+129.10%$2.9M+0.00%10b5-1Stalk
May 28, 2026SellPGENDonald P. LehrChief Legal Officer29,131$4.36$2.5B-11.21%+129.10%$127.0K-3.71%Stalk
May 28, 2026SellPGENPhil TennantChief Commercial Officer30,272$4.36$2.5B-11.21%+129.10%$132.0K-17.84%Stalk
May 28, 2026SellPGENHarry Jr. ThomasianChief Financial Officer41,884$4.36$2.5B-11.21%+129.10%$182.6K-7.02%Stalk
May 28, 2026SellPGENRutul R ShahChief Operating Officer42,703$4.36$2.5B-11.21%+129.10%$186.2K-7.90%Stalk
May 28, 2026SellPGENHelen SabzevariPresident and CEO119,250$4.36$2.5B-11.21%+129.10%$519.9K-3.07%Stalk
Sep 29, 2025BuyPGENPhil TennantChief Commercial Officer6,000$3.58$2.5B-11.21%+129.10%$21.5K+10.16%Stalk
Sep 26, 2025BuyPGENRutul R ShahChief Operating Officer2,000$3.40$2.5B-11.21%+129.10%$6.8K+0.50%Stalk
Sep 25, 2025BuyPGENHarry Jr. ThomasianChief Financial Officer11,216$3.57$2.5B-11.21%+129.10%$40.0K+1.22%Stalk
May 16, 2025SellPGENPhil TennantChief Commercial Officer22,969$1.45$2.5B-11.21%+129.10%$33.3K-28.01%Stalk
May 16, 2025SellPGENHarry Jr. ThomasianChief Financial Officer51,441$1.45$2.5B-11.21%+129.10%$74.6K-10.11%Stalk
May 16, 2025SellPGENDonald P. LehrChief Legal Officer55,101$1.45$2.5B-11.21%+129.10%$79.9K-7.48%Stalk
May 16, 2025SellPGENRutul R ShahChief Operating Officer58,096$1.45$2.5B-11.21%+129.10%$84.2K-12.57%Stalk
May 16, 2025SellPGENHelen SabzevariPresident and CEO521,224$1.45$2.5B-11.21%+129.10%$755.8K-13.58%Stalk
Jan 29, 2025SellPGENPhil TennantChief Commercial Officer9,441$1.30$2.5B-11.21%+129.10%$12.3K-37.76%Stalk
Jan 29, 2025SellPGENDonald P. LehrChief Legal Officer20,844$1.30$2.5B-11.21%+129.10%$27.1K-3.52%Stalk
Jan 29, 2025SellPGENRutul R ShahChief Operating Officer47,151$1.30$2.5B-11.21%+129.10%$61.3K-14.09%Stalk
Jan 29, 2025SellPGENHelen SabzevariPresident and CEO286,967$1.30$2.5B-11.21%+129.10%$373.1K-9.42%Stalk
Aug 9, 2024BuyPGENJeffrey Thomas PerezSVP, IP Affairs58,823$0.85$2.5B-11.21%+129.10%$50.0K+8.60%Stalk
Apr 5, 2024SellPGENRutul R ShahChief Operating Officer40,870$1.40$2.5B-11.21%+129.10%$57.2K-11.11%Stalk
Apr 5, 2024SellPGENJeffrey Thomas PerezSVP, IP Affairs44,199$1.40$2.5B-11.21%+129.10%$61.9K-5.94%Stalk
Apr 5, 2024SellPGENDonald P. LehrChief Legal Officer55,075$1.40$2.5B-11.21%+129.10%$77.1K-7.27%Stalk
Apr 5, 2024SellPGENHarry Jr. ThomasianChief Financial Officer67,389$1.40$2.5B-11.21%+129.10%$94.3K-15.58%Stalk
Apr 5, 2024SellPGENHelen SabzevariPresident and CEO410,357$1.40$2.5B-11.21%+129.10%$574.5K-11.08%Stalk